News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: Token Pharmacovigilance
Peter Doshi | May 23, 2017
A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Joshua A. Krisch | Jan 27, 2017
With its purchase of Actelion, Johnson & Johnson’s acquires experimental treatments for pulmonary arterial hypertension and several rare diseases.
Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion
Joshua A. Krisch | Jan 10, 2017
The pharma giant’s purchase of the US firm includes the acquisition of investigative cancer drugs.
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017
A report finds that new medications still take about 12 years to go from patent to patient.
European Drug Regulator Releases Clinical Trial Data
Ben Andrew Henry | Oct 21, 2016
In the initial steps of a campaign to make clinical reports publicly available, the European Medicines Agency has published data on two recently approved drugs.
NYU Halts Studies, Suspends Investigator
Bob Grant | Jun 28, 2016
Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.
Another Drug Price Hike
Bob Grant | Mar 28, 2016
Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.
Abbott Acquires Diagnostics Firm
Kerry Grens | Feb 2, 2016
In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.
Shire to Buy Baxalta for $32 Billion
Tracy Vence | Jan 12, 2016
The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.
Thermo Fisher to Acquire Affymetrix
Tracy Vence | Jan 11, 2016
The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.